Peculiarities of the influenza viruses circulation and their properties during 2018-2019 epidemic season in Russia and countries of the Northern Hemisphere

D. K. Lvov, E. I. Burtseva,E. A. Mukasheva, L. V. Kolobukhina, V. S. Bogdanova, N. V. Bovin, E. L. Feodoritova, S. V. Trushakova, N. V. Breslav, I. M. Kirillov, L. N. Merkulova, I. T. Fedyakina, K. G. Krasnoslobodtsev, O. L. Voronina, E. I. Aksenova, M. S. Kunda, N. N. Ryzhova,S. V. Alkhovsky, R. V. Vartanyan, L. B. Kisteneva, A. G. Rosatkevich, I. S. Kruzhkova, M. V. Bazarova, S. V. Smetanina

Problems of Particularly Dangerous Infections(2019)

引用 2|浏览0
暂无评分
摘要
Objective. To identify the drift variability of influenza viruses during the period of epidemic rise in the incidence of acute respiratory viral infections in the period 2018-2019. The biological and molecular-genetic properties of epidemic strains isolated in certain territories of the Russian Federation were studied and compared with data from the countries of the Northern Hemisphere. Materials and methods. A range of laboratory diagnostic methods has been applied, including immune fluorescence, RT-PCR, sequencing, methods for determining sensitivity to influenza drugs and receptor specificity. Results and discussion. The proportion of influenza viruses was as follows: A (H1N1) pdm09 - 53 %, A (H3N2) - 46 %, B - about 1 %. Cases of severe acute respiratory infections have most often been associated with influenza A(H1N1) pdm09 virus. According to antigenic properties, isolated strains corresponded to the properties of vaccine viruses (A/Michigan/45/2015 - by 99.6 % and A/Singapore INFIMH-16-0019/2016 - by 86 %). The heterogeneity of influenza A virus strains population was revealed as regards individual mutations in hemaglutinin. The influenza B virus population was equally represented by both evolutionary lines (B/Victoria and B/Yamagata-like). Receptor specificity was favorable for the course and outcome of the disease. Among 70 studied epidemic strains, no strains resistant to anti-neuraminidase drugs, oseltamivir and zanamivir, were detected. The article presents WHO recommendations on the composition of influenza vaccines for the countries of the Northern Hemisphere for 2019-2020, provides data on cases of human infection with avian influenza viruses A(H5N1), A(H5N6), A(H7N9) and A(H9N2).
更多
查看译文
关键词
family orthomyxoviridae,epidemic season 2018-2019,biosafety,morbidity,antigenic properties,genetic peculiarities,receptor affinity,sensitivity to neuraminidase inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要